GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Greenrose Holding Co (OTCPK:GNRS) » Definitions » EBITDA Margin %

The Greenrose Holding Co (The Greenrose Holding Co) EBITDA Margin % : -263.92% (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is The Greenrose Holding Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. The Greenrose Holding Co's EBITDA for the three months ended in Sep. 2022 was $-20.72 Mil. The Greenrose Holding Co's Revenue for the three months ended in Sep. 2022 was $7.85 Mil. Therefore, The Greenrose Holding Co's EBITDA margin for the quarter that ended in Sep. 2022 was -263.92%.


The Greenrose Holding Co EBITDA Margin % Historical Data

The historical data trend for The Greenrose Holding Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Greenrose Holding Co EBITDA Margin % Chart

The Greenrose Holding Co Annual Data
Trend Dec19 Dec20 Dec21
EBITDA Margin %
- 58.75 -

The Greenrose Holding Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.22 - -39.74 17.88 -263.92

Competitive Comparison of The Greenrose Holding Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, The Greenrose Holding Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Greenrose Holding Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Greenrose Holding Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where The Greenrose Holding Co's EBITDA Margin % falls into.



The Greenrose Holding Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

The Greenrose Holding Co's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=0/0
= %

The Greenrose Holding Co's EBITDA Margin % for the quarter that ended in Sep. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-20.715/7.849
=-263.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Greenrose Holding Co  (OTCPK:GNRS) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


The Greenrose Holding Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of The Greenrose Holding Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


The Greenrose Holding Co (The Greenrose Holding Co) Business Description

Traded in Other Exchanges
Address
111 Broadway, Amityville, NY, USA, 11701
The Greenrose Holding Co is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona.
Executives
Bernard Wang officer: CHIEF FINANCIAL OFFICER 5575 TERRACE DR., LA CRESCENTA CA 91214
Benjamin Rose director 10115 JEFFERSON BOULEVARD, CULVER CITY CA 90232
True Harvest, Llc 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Michael Macchiaroli 10 percent owner 4216 N. 43RD STREET, PHOENIX AZ 85018
Scott Jeffrey Cohen officer: Chief Financial Officer C/O GREENROSE ASSOCIATES LLC, 111 BROADWAY, AMITYVILLE NY 11701
Greenrose Associates Llc 10 percent owner 1000 WESTBURY AVENUE, WESTBURY NY 11590
Steven Francis Cummings director, 10 percent owner 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
Daniel Patrick Harley director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE 212, WOODBURY NY 11797
John Iii Torrance director, 10 percent owner 1000 WOODBURY ROAD, WOODBURY NY 11797
Thomas J Megale director 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
John Falcon director, 10 percent owner 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Jeffrey Stegner 10 percent owner, officer: Chief Financial Officer 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
Brendan Sheehan director, 10 percent owner, officer: Executive Vice-President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797
William Iii Harley director, 10 percent owner, officer: Chief Executive Officer 1000 WOODBURY ROAD, WOODBURY NY 11797
Paul Otto Wimer 10 percent owner, officer: President 1000 WOODBURY ROAD, SUITE #212, WOODBURY NY 11797